HirshJ, GentonE, HullR.Pathogenesis of venous thromboembolism. In: Venous thromboembolism. New York: Grune & Stratton Inc, 1981:5-19.
2.
HirshJ, GentonE, HullR.Risk factors in thrombosis. In: Venous thromboembolism. New York: Grune & Stratton Inc, 1981:19-42.
3.
CadeJF. High risk of the critically ill for venous thromboembolism. Crit Care Med1982;7:448–450.
4.
HirshJ.Noninvasive tests for thromboembolic disease. Hosp Pract1982. Sep;17(9):77–85,89–93.
5.
MoserKM, LeMoineJR. Is emboli risk conditional by location of deep venous thrombosis?Ann Intern Med1981;94:439–444.
6.
HullR, HirshJ, SackettDL, PowersP, TurpilAGG, WalkerI.Combined use of leg scanning and impedance plethys-mograph in suspected venous thrombosis. N Engl J Med1977;296:1497–1500.
7.
HullR, HirshJ, SackettDL, StoddardB.Cost effectiveness of clinical diagnosis, venography and non-invasive testing in patients with symptomatic deep vein thrombosis. N Engl J Med1981;301:1561–1567.
8.
HirshJ, GentonE, HullR.A practical approach to the prophylaxis of venous thrombis. In: Venous thromboem-bolism. New York: Grune & Stratton Inc, 1981:108–122.
9.
KakkarVV, CorriganTP, FossardDP, . Prevention of fatal post-operative pulmonary embolism by low doses of heparin: An international multicentre trial. Lancet1975;2:45–50.
10.
KakkarVV. The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg1978;2:3–18.
11.
HalkinH, GoldbertJ, ModanM, ModanB.Reduction of mortality in general medical in-patients by low dose heparin prophylaxis. Ann Intern Med1982;96:561–565.
12.
BelchJJ, LowGDO, WardAG, ForbesCD, PrenticeCRM. Prevention of deep vein thrombis in medical patients by low dose heparin. Scott Med J1981;26:115–117.
13.
PingletonSK, BoneRC, PingletonWW, RuthWE. Prevention of pulmonary emboli in a respiratory intensive care unit. Chest1981;79:647–650.
HullR, DelmoreT, GentonE, . Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med1979;301:855–858.
16.
LeyvrazPF, RichardJ, BachmannF, . Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med1983;309:954–958.
HyersTM. Thrombolytic therapy. Clinical Challenge in Cardiopulmonary Medicine1981;3:1–4.
21.
MansouriA, LipschitzDA. Management of hemostatic abnormalities in critically ill patients. In: BoneRC, ed. Critical care: A comprehensive approach. Park Ridge IL: American College of Chest Physicians, 1984:98–111.
22.
(Pingleton)HarrisSK, BoneRC, RuthWE. Gastrointestinal hemorrhage in a respiratory intensive care unit. Chest1977;72:301–304.
23.
BeardMEJ, HatipovCS, HamerJW. Acute onset of folate deficiency in patients under intensive care. Crit Care Med1980;8:500–503.
24.
BoneRC, FrancisPB, PierceAK. Intravascular coagulation associated with the adult respiratory distress syndrome. Am J Med1976;61:585–589.
25.
HellgrenM, EgbergN, EklundJ.Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients. Intensive Care Med1984;10:23–28.
26.
SchneiderRC, ZapolWM, CarvalhoAC. Platelet consumption and sequestration in severe acute respiratory failure. Am Rev RespirDis1980;122:445–451.
27.
KimYL, RichmanKA, MarshallBE. Thrombocytopenia associated with Swan-Ganz catheterization in patients. Anesthesiology1980;53:261–262.
28.
ColmanRW, MinnaJD, RobboySJ. Disseminated intravascular coagulation: A problem in critical care medicine. Heart Lung1974;3:789–792.
29.
ShapiroSS, HultenM.Acquired inhibitors to the blood coagulation factor. Semin Thromb Hemost1975;1:336–345.
30.
RappaportSI. Preoperative hemostatic evaluation: Which tests, if any. Blood1983;61:229–231.
31.
MerskeyC.Defibrination syndrome. In: BiggsR, ed. Human blood coagulation, haemostasis and thrombosis. Oxford: Blackwell Scientific Publications, 1972;444.
32.
PrenticeCRM. Heparin and disseminated intravascular coagulation. In: KakkarVV, ThomasDP, ed. Heparin: Chemistry and clinical usage. London: Academic Press, 1976:219.
